UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRXL
876
DELISTED
Parexel International Corp
PRXL
| $8.23M | 0.01% |
155,698
-34,100
| -18% | -$1.71M |
|
|
GPOR
877
DELISTED
Gulfport Energy Corp.
GPOR
| $8.15M | 0.01% |
129,813
-7,511
| -5% | -$504K |
|
878
Emergent Biosolutions
EBS
$394M
| $8.13M | 0.01% |
361,806
-246,688
| -41% | -$5.75M |
|
879
Universal Display
OLED
$3.9B
| $8.12M | 0.01% |
252,973
+35,343
| +16% | +$986K |
|
|
LHO
880
DELISTED
LaSalle Hotel Properties
LHO
| $8.11M | 0.01% |
229,913
+3,976
| +2% | +$132K |
|
881
LSB Industries
LXU
$708M
| $8.07M | 0.01% |
251,891
-14,634
| -5% | -$436K |
|
882
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $7.98M | 0.01% |
191,004
+44,581
| +30% | +$1.91M |
|
883
W.P. Carey
WPC
$16.5B
| $7.94M | 0.01% |
125,926
+8,270
| +7% | +$504K |
|
884
Hilton Worldwide
HLT
$70.4B
| $7.93M | 0.01% |
113,433
+50,166
| +79% | +$3.34M |
|
885
First Solar
FSLR
$26.2B
| $7.9M | 0.01% |
111,178
+1,991
| +2% | +$132K |
|
|
DHC
886
Diversified Healthcare Trust
DHC
$2.15B
| $7.87M | 0.01% |
326,785
+20,079
| +7% | +$469K |
|
887
Highwoods Properties
HIW
$3.67B
| $7.87M | 0.01% |
187,480
+4,372
| +2% | +$176K |
|
888
Lear
LEA
$6.08B
| $7.85M | 0.01% |
87,859
-43,920
| -33% | -$3.78M |
|
889
Ciena
CIEN
$59.2B
| $7.84M | 0.01% |
362,196
-33,980
| -9% | -$698K |
|
890
Pediatrix Medical
MD
$2.06B
| $7.78M | 0.01% |
133,793
-8,837
| -6% | -$520K |
|
|
WBC
891
DELISTED
WABCO HOLDINGS INC.
WBC
| $7.75M | 0.01% |
72,540
+25,923
| +56% | +$2.78M |
|
|
ANN
892
DELISTED
ANN INC
ANN
| $7.73M | 0.01% |
187,879
-19,596
| -9% | -$782K |
|
|
PGH
893
DELISTED
Pengrowth Energy Corporation
PGH
| $7.71M | 0.01% |
1,073,583
+35,509
| +3% | +$232K |
|
894
ATI
ATI
$27.1B
| $7.71M | 0.01% |
170,894
-1,600
| -0.9% | -$65.5K |
|
|
HOS
895
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $7.66M | 0.01% |
163,277
-56,237
| -26% | -$2.39M |
|
|
SFLY
896
DELISTED
Shutterfly, Inc.
SFLY
| $7.57M | 0.01% |
175,775
-16,763
| -9% | -$686K |
|
|
PES
897
DELISTED
Pioneer Energy Services Corp.
PES
| $7.56M | 0.01% |
431,035
-386,300
| -47% | -$5.79M |
|
898
KT
KT
$8.88B
| $7.51M | 0.01% |
496,000
+114,300
| +30% | +$1.74M |
|
899
LXP Industrial Trust
LXP
$3.57B
| $7.49M | 0.01% |
136,028
-7,900
| -5% | -$438K |
|
|
WUBA
900
DELISTED
58.com Inc
WUBA
| $7.44M | 0.01% |
+137,700
| New | +$5.84M |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.